Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/1994
06/28/1994US5324646 Joining foreign DNA to carrier particles, then bombarding cells of immature cotyledons with the particles (after pollination) for insertion of DNA into cells yields genetically engineered alfalfa
06/28/1994US5324645 Vector for gene amplification; does not contain a long terminal repeat sequence
06/28/1994US5324643 By interfering with one or more of the infection processes including retroviral replication and assembly into infective viral particles
06/28/1994US5324641 DNA sequences encoding insulin precursors and methods of production
06/28/1994US5324640 Human B-cell differentiation factor and process of producing said factor
06/28/1994US5324639 Culture product; genetic expression
06/28/1994US5324637 Adjusting magnesium concentration by addition of magnesium salt
06/28/1994US5324632 Nucleic acid probes and methods for detecting fungi
06/28/1994US5324513 Composition useful for the fabrication of vaccines
06/28/1994CA1330426C Method for producing a heterologous protein in insect cells
06/28/1994CA1330425C Baculovirus expression system capable of producing foreign gene proteins at high levels
06/28/1994CA1330420C Compositions containing growth hormone peptide fragments
06/24/1994CA2112193A1 Process for preparing recombinant and synthetic peptides, and their use
06/24/1994CA2111630A1 Method for producing azadirachtin
06/23/1994WO1994013834A1 Method of cytogenetic analysis
06/23/1994WO1994013833A1 Ribozyme amplified diagnostics
06/23/1994WO1994013832A1 Improved method for amplification of targeted segments of nucleic acid using nested polymerase chain reaction
06/23/1994WO1994013831A1 A highly sensitive method for detecting environmental insults
06/23/1994WO1994013825A2 A disease resistance gene from maize as a selectable marker and gene identification probe
06/23/1994WO1994013824A1 Retroviral vectors for the treatment of tumors, and cell lines containing them
06/23/1994WO1994013823A1 Nucleotide sequence for treating cancer and infection
06/23/1994WO1994013822A2 Methods for stable transformation of wheat
06/23/1994WO1994013821A1 The use of the kluyveromyces marxianus inulinase gene promoter for protein production
06/23/1994WO1994013820A1 Production of heterologous proteins in filamentous fungi
06/23/1994WO1994013819A1 Expression system for producing apolipoprotein ai-m
06/23/1994WO1994013818A1 Identification of compounds modulations protein/cell membrane association
06/23/1994WO1994013817A1 Genetically engineered glutaminase and its use in antiviral and anticancer therapy
06/23/1994WO1994013816A1 Recombinant canine gastric lipase and pharmaceutical compositions
06/23/1994WO1994013815A1 Dna encoding chitin deacetylase
06/23/1994WO1994013814A1 Dna encoding 2-acyltransferases
06/23/1994WO1994013813A1 Cells with altered betaine catabolism, their preparation and their use, in particular for producing metabolites or enzymes
06/23/1994WO1994013812A2 Novel entomopoxvirus genes, proteins and methods of use thereof
06/23/1994WO1994013811A1 New polypeptides, nucleic acid sequences encoding them, and their use to prevent the adhesion of f107-fimbriated bacteria
06/23/1994WO1994013810A1 A proteinase inhibitor, precursor thereof and genetic sequences encoding same
06/23/1994WO1994013809A1 Developmental regulation in anther tissue of plants
06/23/1994WO1994013808A2 LYMPHOTOXIN-β, LYMPHOTOXIN-β COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF
06/23/1994WO1994013807A1 Clotting inhibitor made from protostomia saliva
06/23/1994WO1994013806A1 Multivalent single chain antibodies
06/23/1994WO1994013805A1 Humanised antibodies directed against a33 antigen
06/23/1994WO1994013804A1 Multivalent and multispecific binding proteins, their manufacture and use
06/23/1994WO1994013803A1 Dna sequence encoding the cpg-1 neural polypeptide and the polypeptide encoded thereby
06/23/1994WO1994013802A1 D4 gene and methods of use thereof
06/23/1994WO1994013801A1 Mammalian receptors for interleukin-10 (il-10)
06/23/1994WO1994013799A1 Stably transfected cell lines expressing gaba-a receptors
06/23/1994WO1994013797A1 Dna molecules encoding inducible plant promoters and tomato adh2 enzyme
06/23/1994WO1994013796A1 Expression cloning of a human phosphatase
06/23/1994WO1994013795A1 Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications
06/23/1994WO1994013794A1 Human thrombospondin-4
06/23/1994WO1994013793A1 Compounds and methods for the treatment of leukemias
06/23/1994WO1994013791A1 Regulatable nucleic acid therapeutic and methods of use thereof
06/23/1994WO1994013790A1 Use of a dna sequence coding for an oxalic acid degrading protein as a selection gene
06/23/1994WO1994013789A2 Oligonucleotides with rna cleavage activity
06/23/1994WO1994013788A1 Recombinant viral vector system
06/23/1994WO1994013787A1 Method for enhancing the differentiation of plant cells in culture
06/23/1994WO1994013785A2 Novel bacillus thuringiensis strains active against lepidopteran and coleopteran pests
06/23/1994WO1994013701A2 Delta-like gene expressed in neuroendocrine tumors
06/23/1994WO1994013700A1 Peptides from the c33 region of hcv, antibodies thereto and methods for the detection of hcv
06/23/1994WO1994013699A1 Hepatitis c virus (hcv) non-structural-3 peptides, antibodies thereto and methods for the detection of hcv
06/23/1994WO1994013689A1 METHODS AND COMPOSITIONS FOR cDNA SYNTHESIS
06/23/1994WO1994013688A1 Dna-armed ribozymes and minizymes
06/23/1994WO1994013326A1 Formation of triple helix complexes using a novel motif
06/23/1994WO1994013315A1 A novel eukaryotic transcription protein: host cell factor
06/23/1994WO1994013303A1 Administration of oligonucleotides antisense to dopamine receptor mrna for diagnosis and treatment of neurological pathologies
06/23/1994WO1994013273A1 Sequences useful for obtaining high level, copy number-dependent, essentially position-independent gene expression in cellular and transgenic systems
06/23/1994WO1994013264A1 Clostridial toxin disease therapy
06/23/1994WO1994009836A3 Methods and procedures for preparing red blood fractions
06/23/1994WO1994009126A3 Acyl coenzyme a: cholesterol acyltransferase (acat)
06/23/1994WO1994008023A3 Biotechnological method of producing biotin
06/23/1994WO1994002620A3 An improved method of agrobacterium-mediated transformation of cultured soybean cells
06/23/1994DE4242638A1 Analysing transcription patterns of gene and multi-gene families
06/23/1994CA2151831A1 A disease resistance gene from maize as a selectable marker and gene identification probe
06/23/1994CA2151587A1 Process for promoting the differenciation of plant cells during culture
06/23/1994CA2151585A1 Administration of oligonucleotides antisense to dopamine receptor mrna for diagnosis and treatment of neurological pathologies
06/23/1994CA2151496A1 Nucleotide sequence for treating cancer and infection
06/23/1994CA2151484A1 Methods and compositions for cdna synthesis
06/23/1994CA2151455A1 Delta-like gene expressed in neuroendocrine tumors
06/23/1994CA2151267A1 Developmental regulation in anther tissue of plants
06/23/1994CA2151263A1 Formation of triple helix complexes using a novel motif
06/23/1994CA2151257A1 Dna encoding chitin deacetylase
06/23/1994CA2151147A1 Dna encoding 2-acyltransferases
06/23/1994CA2151128A1 Hepatitis c virus (hcv) non-structural-3 peptides, antibodies thereto and methods for the detection of hcv
06/23/1994CA2151126A1 Peptides from the c33 region of hcv, antibodies thereto and methods for the detection of hcv
06/23/1994CA2151036A1 Improved method for amplification of targeted segments of nucleic acid using nested polymerase chain reaction
06/23/1994CA2150935A1 Clostridial toxin disease therapy
06/23/1994CA2150909A1 Clotting inhibitor made from protostomia saliva
06/23/1994CA2150903A1 Compounds for the treatment of leukemias
06/23/1994CA2150807A1 Dna sequence encoding the cpg-1 neutral polypeptide and the polypeptide encoded thereby
06/23/1994CA2150536A1 Retroviral vectors for the treatment of tumors, and cell lines containing them
06/23/1994CA2150249A1 Lymphotoxin-.beta., lymphotoxin-.beta. complexes, pharmaceutical preparations and therapeutic uses thereof
06/23/1994CA2128544A1 Humanised antibodies directed against a33 antigen
06/23/1994CA2112046A1 Antibodies, polypeptides, production and use thereof
06/23/1994CA2112018A1 Porcine grf receptor
06/23/1994CA2110852A1 Monoclonal antibodies that define a unique antigen of human b cell receptor complex and methods of using same for diagnosis and treatment
06/22/1994EP0603128A1 Process for the production of polypeptides
06/22/1994EP0602899A2 Modified proteins containing controllable intervening sequences and methods of their production
06/22/1994EP0602688A1 Methionine free G-CSf from prokaryotes
06/22/1994EP0602687A1 Modified VP1/P2A regions of rhinovirus systems
06/22/1994EP0602237A1 N-acetylglucosaminyltransferase v coding sequences
06/22/1994EP0602193A1 Enhanced expression in plants
06/22/1994EP0602189A1 Nucleic sequence of the gene associated with x-linked kallmann syndrome, corresponding peptide sequences, diagnostic applications